Angiotensin receptor blockers (ARBs) showed no clear difference in adverse events (episodes of peritonitis) compared with conventional therapy (low certainty).

1 finding from 1 review

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
RR 0.67 [0.18, 2.54]
1 study · 34 participants
Low

Angiotensin receptor blockers (ARBs) vs conventional therapy

Residual kidney function (12 months) · patients receiving PD

1 finding from 1 review

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 44 participants
Moderate

Angiotensin receptor blockers (ARBs) vs conventional therapy

Urinary protein excretion · patients receiving PD

1 finding from 1 review

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 66 participants
Low

Angiotensin receptor blockers (ARBs) vs conventional therapy

Kt/V · patients receiving PD

1 finding from 1 review

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 76 participants
Moderate

Angiotensin receptor blockers (ARBs) vs conventional therapy

Creatinine clearance · patients receiving PD

1 finding from 1 review

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 110 participants
Low

Angiotensin receptor blockers (ARBs) vs conventional therapy

Systolic blood pressure · patients receiving PD

1 finding from 1 review

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 110 participants
Moderate